후두 마스크 시장 : 세계 시장 예측(2026-2032년)

The Laryngeal Mask Market is projected to grow by USD 1,091.67 million at a CAGR of 6.03% by 2032.

Laryngeal Mask Market Executive Summary

The laryngeal mask has become a critical supraglottic airway device used across operating rooms, emergency departments, ambulatory surgical centers, and prehospital care settings to support airway management without routine tracheal intubation. Its clinical relevance is reinforced by established anesthesia practice, difficult-airway algorithms, and growing demand for rapid, reliable ventilation during elective surgery, short procedures, resuscitation, and rescue airway scenarios. Modern laryngeal mask airway designs emphasize improved anatomical fit, higher airway seal performance, gastric access in second-generation devices, reduced aspiration risk, and simplified insertion for trained clinicians. Demand is shaped by rising surgical volumes, increased adoption of day-care procedures, broader anesthesia workforce training, and the need for airway devices that balance patient safety, procedural efficiency, and cost control. SEO-relevant themes in the laryngeal mask industry include supraglottic airway device innovation, disposable laryngeal mask adoption, reusable airway device sterilization standards, anesthesia airway management, pediatric laryngeal mask use, emergency airway rescue, and operating room efficiency.

Transformative Shifts in the Laryngeal Mask Landscape

The laryngeal mask landscape is shifting from basic airway support toward procedure-specific, safety-centered airway management. Second-generation supraglottic airway devices with integrated gastric drainage channels, better cuffs, and improved sealing pressures are increasingly preferred in settings where aspiration mitigation and controlled ventilation are priorities. Single-use laryngeal masks are gaining attention as healthcare facilities strengthen infection prevention protocols and reduce reprocessing variability, while reusable devices remain relevant where procurement efficiency and validated sterilization infrastructure are strong. Clinical training is also changing the market dynamic, as simulation-based airway education enables anesthesiologists, nurse anesthetists, emergency physicians, and paramedics to improve insertion technique and rescue-airway readiness. Another major shift is the expansion of ambulatory and minimally invasive procedures, where fast airway placement, predictable recovery, and reduced anesthesia time are valued. Regulatory and procurement scrutiny are also intensifying, with healthcare systems prioritizing materials safety, biocompatibility, device traceability, and compliance with recognized airway management standards.

Cumulative Impact of Artificial Intelligence on Laryngeal Mask Adoption

Artificial intelligence is beginning to influence the laryngeal mask ecosystem through decision support, training optimization, workflow analytics, and device performance monitoring rather than through the device alone. In perioperative care, AI-enabled anesthesia information systems can help identify patients at higher risk of difficult airway events by integrating clinical history, body mass index, comorbidities, imaging signals, and prior anesthesia records, supporting more informed selection between a laryngeal mask, endotracheal tube, or alternative airway plan. In education, AI-supported simulation platforms can analyze insertion angle, timing, ventilation success, and user errors, enabling targeted training for clinicians who use supraglottic airway devices in routine and emergency care. In hospital operations, analytics can support inventory management by tracking usage patterns of disposable and reusable laryngeal masks, helping reduce stockouts and unnecessary waste. AI may also strengthen post-market surveillance by detecting adverse event patterns, cuff performance concerns, or device-related complications in clinical documentation. However, adoption depends on validated datasets, clinician oversight, cybersecurity safeguards, interoperability with anesthesia systems, and compliance with medical device and health data regulations.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, the Middle East, and Africa

Asia-Pacific is supported by expanding surgical capacity, rising investment in hospital infrastructure, and increasing adoption of modern anesthesia practices across tertiary and secondary care settings, with China, India, Japan, South Korea, and Australia contributing to broader use of supraglottic airway devices. North America demonstrates mature adoption due to advanced anesthesia protocols, well-established ambulatory surgery networks, strong emergency medical services, and consistent emphasis on difficult-airway preparedness. Latin America is characterized by improving access to surgical care and rising use of cost-effective airway management tools, although procurement variability and differences in hospital resources influence device selection. Europe shows high alignment with evidence-based anesthesia guidelines, infection control standards, and sustainability considerations, creating demand for both single-use and reusable laryngeal mask options depending on national procurement policies and sterilization capabilities. The Middle East is benefiting from expanding specialist hospitals, medical tourism, and modernization of emergency care systems, particularly in high-investment health economies. Africa presents a diverse landscape in which laryngeal masks are valuable for anesthesia delivery and rescue ventilation, especially where access to specialist airway expertise may vary, but adoption is shaped by training availability, supply continuity, and public-sector purchasing capacity.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN healthcare systems are expanding surgical and emergency care capacity, making laryngeal masks relevant for operating rooms, ambulatory procedures, and airway training programs across both public and private providers. GCC countries are advancing hospital modernization, specialist anesthesia services, and emergency response systems, supporting adoption of advanced supraglottic airway devices that align with international clinical practice. The European Union places strong emphasis on medical device regulation, patient safety, infection prevention, and environmental stewardship, which influences procurement decisions between disposable and reusable laryngeal mask formats. BRICS countries reflect a high-volume care environment where affordability, scalable training, domestic healthcare investment, and access to essential surgical devices shape demand for airway management solutions. G7 nations generally exhibit mature anesthesia infrastructure, strong clinical governance, high adoption of difficult-airway protocols, and greater integration of digital perioperative systems that support standardized laryngeal mask use. NATO member countries, particularly those with advanced military and emergency medical capabilities, reinforce the importance of portable, reliable supraglottic airway devices for trauma care, field medicine, and rapid airway rescue in austere or high-pressure environments.

Key Country Insights Across Major Laryngeal Mask Markets

The United States leads in protocol-driven anesthesia care, ambulatory surgery utilization, and emergency airway training, supporting broad use of laryngeal masks across hospitals and outpatient centers. Canada emphasizes patient safety, standardized clinical practice, and public health procurement discipline, with laryngeal masks used in surgical anesthesia and rescue airway settings. Mexico is seeing broader use of supraglottic airway devices as surgical access improves and private healthcare providers invest in modern anesthesia equipment. Brazil's large hospital network and surgical demand support laryngeal mask adoption, particularly where efficient airway management is needed across high-volume care settings. The United Kingdom has strong alignment with difficult-airway guidance and clinician training, reinforcing structured use of second-generation supraglottic airway devices. Germany's advanced surgical infrastructure and strict device quality expectations support demand for reliable, compliant laryngeal mask products. France combines robust anesthesia standards with hospital procurement controls, encouraging evidence-based selection of airway devices. Russia's adoption is shaped by regional differences in hospital infrastructure, surgical service availability, and procurement access. Italy and Spain show steady reliance on laryngeal masks in anesthesia practice, especially in elective and ambulatory procedures where rapid placement and recovery are important. China is expanding modern surgical and anesthesia capacity across urban and regional hospitals, increasing clinical exposure to supraglottic airway devices. India's demand is supported by rising surgical procedures, growing anesthesia training, and the need for scalable airway solutions across diverse healthcare settings. Japan emphasizes safety, device quality, and advanced perioperative care, supporting use of anatomically refined airway devices. Australia has strong emergency medicine and anesthesia training systems, promoting effective use of laryngeal masks in both routine and rescue care. South Korea's sophisticated hospital infrastructure and high procedural standards support adoption of advanced airway management devices in operating rooms and emergency settings.

Actionable Recommendations for Laryngeal Mask Industry Leaders

Industry leaders should prioritize clinically differentiated laryngeal mask designs that improve airway seal, reduce insertion trauma, support gastric drainage, and accommodate diverse patient anatomies across adult, pediatric, and specialty procedures. Manufacturers and suppliers should strengthen evidence generation through clinical usability studies, post-market surveillance, and training partnerships that demonstrate safety, insertion success, and workflow efficiency. Procurement strategies should address the practical trade-offs between disposable and reusable laryngeal masks, including infection prevention requirements, sterilization capacity, total lifecycle cost, waste management, and supply chain resilience. Commercial teams should align messaging with anesthesia guidelines, difficult-airway preparedness, ambulatory surgery growth, and emergency airway rescue needs rather than relying on broad product claims. Stakeholders should also invest in clinician education, simulation-based competency programs, and digital tools that support proper device sizing, insertion technique, cuff pressure management, and complication reduction. To remain competitive, industry participants should monitor evolving medical device regulations, sustainability expectations, material safety standards, and hospital value analysis criteria.

Research Methodology for Laryngeal Mask Industry Analysis

The research methodology for analyzing the laryngeal mask industry should combine verified secondary research, structured primary insights, regulatory review, and clinical evidence assessment. Secondary research includes peer-reviewed anesthesia literature, clinical practice guidelines, public health data, medical device regulatory databases, hospital procurement frameworks, and infection prevention standards. Primary research should include interviews with anesthesiologists, emergency physicians, nurse anesthetists, operating room managers, procurement specialists, biomedical engineers, and infection control professionals to validate real-world device selection criteria. The assessment should examine product design attributes such as cuff type, airway seal, gastric access, disposability, reusability, material composition, sizing range, and compatibility with clinical workflows. Regional and country-level analysis should consider healthcare infrastructure, surgical access, anesthesia workforce availability, regulatory requirements, reimbursement environment, training standards, and emergency care readiness. All findings should be triangulated across clinical, operational, and regulatory sources to ensure accuracy while avoiding unsupported assumptions, unverified projections, or speculative market sizing.

Conclusion

The laryngeal mask remains an essential airway management device because it supports efficient ventilation, difficult-airway rescue, and anesthesia delivery across diverse care environments. The industry is being shaped by second-generation device innovation, infection prevention priorities, ambulatory surgery growth, simulation-based training, and increasing focus on standardized airway protocols. Regional adoption differs according to healthcare infrastructure, clinician training, procurement policy, and emergency care capability, while AI-enabled systems are beginning to enhance airway risk assessment, education, inventory control, and post-market surveillance. For industry leaders, success depends on combining clinically meaningful design improvements with evidence-backed positioning, strong regulatory compliance, resilient supply chains, and practical clinician education. As hospitals continue to prioritize patient safety and procedural efficiency, laryngeal masks will remain central to modern supraglottic airway management.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Laryngeal Mask Market, by Product Type

• 7.1. Introduction
• 7.2. Disposable
• 7.3. Reusable

8. Laryngeal Mask Market, by Material

• 8.1. Introduction
• 8.2. PVC
• 8.3. Silicone

9. Laryngeal Mask Market, by Size

• 9.1. Introduction
• 9.2. Adult
• 9.3. Neonatal
• 9.4. Pediatric

10. Laryngeal Mask Market, by Application

• 10.1. Introduction
• 10.2. Emergency Airway Management
• 10.3. General Anesthesia

11. Laryngeal Mask Market, by End User

• 11.1. Introduction
• 11.2. Ambulatory Surgical Centers
• 11.3. Hospitals

12. Laryngeal Mask Market, by Distribution Channel

• 12.1. Introduction
• 12.2. Online
• 12.3. Offline

13. Laryngeal Mask Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Laryngeal Mask Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Laryngeal Mask Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2025
• 16.2. FPNV Positioning Matrix, 2025
• 16.3. Market Concentration Analysis, 2025
  • 16.3.1. Concentration Ratio (CR)
  • 16.3.2. Herfindahl Hirschman Index (HHI)
• 16.4. Recent Developments & Impact Analysis, 2025
• 16.5. Product Portfolio Analysis, 2025
• 16.6. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Airway Medix SA
• 17.2. Ambu A/S
• 17.3. Anandic Medical Systems
• 17.4. Besmed Health Business Corp
• 17.5. Dynarex Corporation
• 17.6. Flexicare Medical Limited
• 17.7. Hangzhou Formed Medical Devices Co Ltd
• 17.8. Hitec Medical Co Ltd
• 17.9. Intersurgical Ltd.
• 17.10. KOO Industries Co Ltd
• 17.11. Legend Medical Devices Inc
• 17.12. Marshall Airway Products Ltd
• 17.13. Narang Medical Limited
• 17.14. P3 Medical Ltd
• 17.15. Polymedicure Ltd
• 17.16. Sterimed Medical Devices Pvt Ltd
• 17.17. SunMed LLC
• 17.18. Teleflex Incorporated
• 17.19. VBM Medizintechnik GmbH
• 17.20. Well Lead Medical Co Ltd